ZeroCancer.com – fight cancer through knowledge

Cancer news

Cancer survivors and their caregivers will present their art at the Mistlin Gallery in downtown Mode
The American Cancer Society attempted to add its voice Thursday to the federal court debate over the state taxation of Native American cigarette sales.
Ovarian cancer strikes silently. But on Sept. 25, there will be a lot of noise about it.
People with advanced lung cancer could find it much easier to be treated at home with Pharmac announcing an oral cancer drug will now be funded.
CÁNCER: Será el comienzo hoy de una temporada financiera estable para ti, disfrutarás de bienestar, felicidad y armonía interna.
With temperatures set to plummet below freezing across the UK this week, leading cancer charity Macmillan Cancer Support is warning that keeping warm will be even harder for cancer patients undergoing treatment, as they are already twice as likely to fall into fuel poverty as the general population 1 . Following diagnosis, three-quarters (73 per cent 2 ) of cancer patients in active treatment ...
Health Minister Tony Ryall has welcomed a cancer drug agreement between Pharmac and pharmaceutical company Roche that will enable more patients to get new cancer drugs, and more cancer patients overall to receive treatment.
The actor, who has been diagnosed with stage four throat cancer, reveals that he will continue to fight the disease by showing the public what a cancer fighter looks in stand Up 2 Cancer telethon.
Duelling studies differ over potential links between esophageal cancer and bisphosphonates, widely used after menopause to prevent or treat osteoporosis
Cancer survivors, patients, and those who were left behind have found a new and unique way of coping... and hope it will help others heal, too.

Delayed surgery decreases bladder cancer survival

NEW YORK (Reuters Health) - For patients newly diagnosed with bladder cancer, delays of more than 3 months after the initial diagnosis to surgery results in decreased survival, a study shows.

“There currently are no standardized guidelines for the appropriate timing of cystectomy” (surgical removal of the bladder), Dr. Cheryl T. Lee from University of Michigan, Ann Arbor, Michigan told Reuters Health. “However, there is growing evidence that cystectomy should be performed within 3 months of a diagnosis” of muscle-invasive disease.

The current study, she said, supports that “patients must undergo cystectomy within 3 months of diagnosis or their survival may be compromised.”

Lee and colleagues evaluated the timing from the diagnosis of bladder cancer to cystectomy in 214 consecutive patients to assess its impact on survival.

By investigating each delay duration, the authors were able to identify a delay of 93 days as the first cutoff point that resulted in a significantly decreased overall survival and so-called disease-specific survival.

Three-year disease-specific survival was 62 percent for patients who underwent cystectomy within 93 days of diagnosis and 49 percent for those who underwent surgery later, the researchers note.

Three-year overall survival was 51 percent and 38 percent, respectively, for patients operated within and beyond 93 days of diagnosis.

Patients who had a cystectomy delay of more than 93 days faced about twice the risk of patients who had an earlier cystectomy of dying from any cause or from bladder cancer, according to a multivariate analysis.

Nearly half the scheduling delays in patients who underwent cystectomy after 93 days were related to clinical or research appointments, the investigators say. Patient co-morbidities accounted for 15 percent of the delays, and difficulty with decision-making contributed to 12 percent of the delays.

“Rigorous coordination of preoperative counseling, medical clearance, and patient education is required to permit an efficient decision-making process and timely delivery of surgery,” Lee said.

SOURCE: The Journal of Urology April 2006.

Tags:

▼ Show related feed